Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Intestinal candidiasis. A clinical report and comments about this opportunistic pathology.

Ruiz-Sánchez D, Calderón-Romero L, Sánchez-Vega JT, Tay J.

Mycopathologia. 2002;156(1):9-11.

PMID:
12715941
2.

Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.

Walsh TJ, Pizzo PA.

Eur J Epidemiol. 1992 May;8(3):477-83. No abstract available.

PMID:
1397212
3.

[Fungi in the oro-intestinal tract and their scientifically founded status].

Knoke M.

Z Arztl Fortbild Qualitatssich. 1998 Apr;92(3):157-62. Review. German.

PMID:
9606881
4.

The pathogenetic significance of intestinal Candida colonization.

Crandall M.

Int J Hyg Environ Health. 2004 Jan;207(1):79-81. No abstract available.

PMID:
14762978
5.

[Intestinal mycoses--do they exist?].

Hof H.

Leber Magen Darm. 1993 Sep;23(5):184-5. German. No abstract available.

PMID:
8412466
6.

[Hypersensitivity to "Candida albicans" and other fungi in patients with chronic urticaria].

Serrano H.

Allergol Immunopathol (Madr). 1975 Sep-Oct;3(5):289-98. Spanish.

PMID:
775952
7.

Ibogaine reduces organ colonization in murine systemic and gastrointestinal Candida albicans infections.

Yordanov M, Dimitrova P, Patkar S, Falcocchio S, Xoxi E, Saso L, Ivanovska N.

J Med Microbiol. 2005 Jul;54(Pt 7):647-53.

PMID:
15947429
8.

[Experimental yeast infection of the gastrointestinal tract in the mouse].

Wildfeuer A.

Mykosen. 1978 Jun;21(6):157-66. German. No abstract available.

PMID:
353554
9.

[The identification of freshly isolated strains, the causative agents of human candidiasis and the search for effective antifungal probiotics].

Polishchuk OI, Koltukova NV, Cherniavs'ka LM, Reva OM, Sorokulova IB.

Mikrobiol Z. 1999 Jul-Aug;61(4):45-53. Ukrainian.

PMID:
10565150
10.

[The role of voriconazole in the treatment of emerging mycoses].

Pastor FJ, Guarro J.

Rev Iberoam Micol. 2007 Sep 30;24(3):228-32. Review. Spanish.

11.

[Sensitivity of Candida strains to polyenic antibiotics in the treatment of oral candidiasis].

Boĭko GI, Sosnin GP, Adarchenko AA, Moroz GS.

Antibiotiki. 1984 Nov;29(11):869-72. Russian.

PMID:
6395795
12.

[Invasive candidiasis in the critically ill, patient non-neutropenic].

Schwetz I, Domej W, Krause R.

Wien Med Wochenschr. 2007;157(19-20):490-2. Review. German.

PMID:
18030553
13.

Production of anti-Candida antibodies in mice with gut colonization of Candida albicans.

Tansho S, Abe S, Ishibashi H, Mitsuya M, Wada K, Ikeda T, Suegara N, Koshio O, Ono Y, Yamaguchi H.

Mediators Inflamm. 2004 Jun;13(3):189-93.

14.

[How effective is intestinal treatment of candida infection with nystatin?].

Herfarth H, Layer P.

Med Monatsschr Pharm. 1995 Oct;18(10):299. German. No abstract available.

PMID:
7476657
15.

[Pathogenicity of fungi in the intestines--current status of the discussion].

Scheurlen M.

Fortschr Med. 1996 Sep 20;114(26):319-21. Review. German.

PMID:
8999002
16.

[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].

Tebbe B, Boyvat A, Geilen CC, Wölfer LU, Seibold M, Orfanos CE.

Hautarzt. 1996 Feb;47(2):136-9. German.

PMID:
8868459
18.

Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice.

Khan MA, Nasti TH, Saima K, Mallick AI, Firoz A, Wajahul H, Ahmad N, Mohammad O.

FEMS Immunol Med Microbiol. 2004 Jul 1;41(3):249-58.

19.

Candida keratitis in a patient with candidiasis of the fingernails.

Jradeh EF, Al-Kharashi SA, Tabbar KF.

Eur J Ophthalmol. 2001 Oct-Dec;11(4):380-2.

PMID:
11820312

Supplemental Content

Support Center